Abstract
The number of cases of cutaneous tuberculosis (CTB) is increasing concomitantly with the increase of pulmonary tuberculosis. Migration, increasing immunosuppression factors, and treatment resistance are mainly responsible for this growth. The varied clinical presentation and low sensitivity of conventional tests make CTB a disease difficult to confirm in many cases. Most histopathologic examination has classic findings; however, bacilli frequency is low and atypical granulomas may occur. New tests with lower error rate and higher accuracy are available and should become known. The list of diseases that are differential diagnosis is extensive and beyond the shape of the skin lesion, depending on the location and age. The initial treatment is equal to the pulmonary tuberculosis, but has some particularities, as difficulty in confirming possible drugs’ resistance. This knowledge is essential for coping with the disease in the current scenario.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AFB:
-
Acid-fast bacillus
- AIDS:
-
Acquired immunodeficiency syndrome
- AMTDT:
-
Amplified Mycobacterium tuberculosis Direct Test
- BCG:
-
Bacillus Calmette-Guérin
- COVID-19:
-
Coronavirus disease 2019
- CTB:
-
Cutaneous tuberculosis
- EIB:
-
Erythema Induratum of Bazin
- EN:
-
Erythema nodosum
- HIV:
-
Human immunodeficiency virus
- IGRA:
-
Interferon-γ release assay
- IL:
-
Interleukin
- INF:
-
Interferon
- LV:
-
Lupus vulgaris
- MAC:
-
M. avium-intracellulare complex
- MDA:
-
Multiple displacement amplification
- MTB:
-
Mycobacterium tuberculosis
- MTC:
-
Mycobacterium tuberculosis complex
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
- NTM:
-
Nontuberculous mycobacteria
- PCR:
-
Polymerase chain reaction
- PPD:
-
Purified protein derivative
- RHZ:
-
Rifampicin, isoniazid, and pyrazinamide
- SARS-CoV-19:
-
Severe acute respiratory syndrome coronavirus 2
- TB:
-
Tuberculosis
- TGF:
-
Transforming growth factor
- Th:
-
T-helper
- TST:
-
Tuberculin skin test
- TVC:
-
Tuberculosis verrucosa cutis
- WHO:
-
World Health Organization
References
World Health Organization. Tuberculosis (TB). Global tuberculosis report 2020. https://www.who.int/health-topics/tuberculosis#tab=tab_1. Accessed 11 Dec 2020.
Centers for Disease Control and Prevention. Tuberculosis (TB). https://www.cdc.gov/tb/. Accessed 11 Dec 2020.
Silva DR, Mello FCQ, Migliori GB. Tuberculosis series 2020. J Bras Pneumol. 2020;46(2):e20200027. https://doi.org/10.36416/1806-3756/e20200027.
Tortoli E, Meehan CJ, Grottola A, Serpini GF, et al. Genome-based taxonomic revision detects a number of synonymous taxa in the genus Mycobacterium. Infect Genet Evol. 2019;75:103983. https://doi.org/10.1016/j.meegid.2019.103983.
Gupta RS, Lo B, Son J. Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera. Front Microbiol. 2018;9:67. https://doi.org/10.3389/fmicb.2018.00067.
Kazda J, Pavlik I. Obligate pathogenic mycobacteria. In: Kazda J, Pavlik I, Falkinham III JO, Hruska K, editors. The ecology of mycobacteria: impact on animal’s and human’s health. Netherlands: Springer; 2009. p. 13–20. https://doi.org/10.1007/978-1-4020-9413-2.
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City—turning the tide. N Engl J Med. 1995;333(4):229–33. https://doi.org/10.1056/NEJM199507273330406.
Waaler HT. Tuberculosis and poverty. Int J Tuberc Lung Dis. 2002;6(9):745–6.
Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16(3):463–96. https://doi.org/10.1128/CMR.16.3.463-496.2003.
Brosch R, Gordon SV, Marmiesse M, Brodin P, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. PNAS. 2002;99(6):3684–9. https://doi.org/10.1073/pnas.052548299.
Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, et al. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects—part I. An Bras Dermatol. 2014;89(2):219–28. https://doi.org/10.1590/abd1806-4841.20142334.
Kumar DR, Bhattacharya DB, Meena DV, Soneja DM, Wig DN. COVID-19 and TB co-infection—‘Finishing touch’ in perfect recipe to ‘severity’ or ‘death’. J Infect. 2020;81(3):e39–40. https://doi.org/10.1016/j.jinf.2020.06.062.
Dias MF, Bernardes Filho F, Quaresma MV, Nascimento LV, et al. Update on cutaneous tuberculosis. An Bras Dermatol. 2014;89(6):925–38. https://doi.org/10.1590/abd1806-4841.20142998e.
Singal A, Sonthalia S. Cutaneous tuberculosis in children: the Indian perspective. Indian J Dermatol Venereol Leprol. 2010;76(5):494–503. https://doi.org/10.4103/0378-6323.69060.
Barbagallo J, Tager P, Ingleton R, Hirsch RJ, et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol. 2002;3(5):319–28. https://doi.org/10.2165/00128071-200203050-00004.
Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol. 2009;157(2):235–43. https://doi.org/10.1111/j.1365-2249.2009.03967.x.
Lai-Cheong JE, Perez A, Tang V, et al. Cutaneous manifestations of tuberculosis. Clin Exp Dermatol. 2007;32(4):461–6. https://doi.org/10.1111/j.1365-2230.2007.02352.x.
Frankel A, Penrose C, Emer J. Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol. 2009;2(10):19–27. PMID: 20725570.
World Health Organization. Tuberculosis (TB). Childhood tuberculosis. http://www.who.int/tb/areas-of-work/children/en/. Accessed 10 Dec 2020.
Brasil. Ministério da Saúde. Portal da Saúde. Tuberculose. Brasília; 2016. http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/741-secretaria-svs/vigilancia-de-a-a-z/tuberculose/11485-situacao-epidemiologica-dados. Accessed 10 Dec 2020.
Centers for Disease Control and Prevention. Tuberculosis (TB). Children. http://www.cdc.gov/tb/topic/populations/TBinChildren/default.htm. Accessed 11 Dec 2020.
Euzéby JP. List of prokaryotic names with standing in nomenclature (LPSN). https://lpsn.dsmz.de/genus/mycobacterium. Accessed 9 Dec 2020.
Jagielski T, van Ingen J, Rastogi N, Dziadek J, et al. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int. 2014;2014:645802. https://doi.org/10.1155/2014/645802.
Pavlik I, Falkinham JO III, Kazda J. Potentially pathogenic mycobacteria. In: Kazda J, Pavlik I, Falkinham III JO, Hruska K, editors. The ecology of mycobacteria: impact on animal’s and human’s health. Dordrecht: Springer; 2009. p. 21–79. https://doi.org/10.1007/978-1-4020-9413-2.
Saini C, Kumar P, Tarique M, Sharma A, et al. Regulatory T cells antagonize proinflammatory response of IL-17 during cutaneous tuberculosis. J Inflamm Res. 2018;11:377–88. https://doi.org/10.2147/JIR.S172878.
Sekiguchi A, Motegi S, Ishikawa O. Erythema induratum of Bazin associated with bacillus Calmette-Guérin vaccination: implication of M1 macrophage infiltration and monocyte chemotactic protein-1 expression. J Dermatol. 2016;43(1):111–3. https://doi.org/10.1111/1346-8138.13148.
Huang Z, Luo Q, Guo Y, et al. Mycobacterium tuberculosis-induced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro. PLoS One. 2015;10(6):e0129744. https://doi.org/10.1371/journal.pone.0129744.
Piccoli BTB, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131–46. https://doi.org/10.1007/s12016-017-8666-8.
Paredes CF, Marcos LA, Martínez AFH, Morales AJR, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1):e00069–18. https://doi.org/10.1128/CMR.00069-18.
Chen Q, Chen W, Hao F. Cutaneous tuberculosis: a great imitator. Clin Dermatol. 2019;37:192–9. https://doi.org/10.1016/j.clindermatol.2019.01.008.
Sehgal VN, Bhattacharya SN, Jain S, Logani K. Cutaneous tuberculosis: the evolving scenario. Int J Dermatol. 1994;33(2):97–105. https://doi.org/10.1111/j.1365-4362.1994.tb01534.x.
Concha RM, Fich FS, Rabagliati RB, Pinto CS, et al. Cutaneous tuberculosis: two case reports and review. Rev Chilena Infectol. 2011;28(3):262–8. https://doi.org/10.4067/S0716-10182011000300011.
Collins FM. Tuberculosis research in a cold climate. Tuber Lung Dis. 1998;78(2):99–107. https://doi.org/10.1016/S0962-8479(98)80002-6.
Fortaleza GTM, Brito MFM, Santos JB, Figueiredo AR, et al. Splenic tuberculosis during psoriasis treatment with infliximab. An Bras Dermatol. 2009;84:420–4. https://doi.org/10.1590/S0365-05962009000400016.
Puri N. A clinical and histopathological profile of patients with cutaneous tuberculosis. Indian J Dermatol. 2011;56:550–2. https://doi.org/10.4103/0019-5154.87153.
Murry WT, Sharma S, Arora VK, Bhattacharya SN, et al. Cytomorphological spectrum and immunochemistry of cutaneous tuberculosis. Diagn Cytopathol. 2018;47(5):458–68. https://doi.org/10.1002/dc.24138.
Sethuraman G, Ramesh V. Cutaneous tuberculosis in children. Pediatr Dermatol. 2013;30(1):7–16. https://doi.org/10.1111/j.1525-1470.2012.01794.x.
Zhang J, Fan YK, Wang P, Chen QQ, et al. Cutaneous tuberculosis in China—a multicentre retrospective study of cases diagnosed between 1957 and 2013. J Eur Acad Dermatol Venereol. 2018;32(4):632–8. https://doi.org/10.1111/jdv.14851.
Spelta K, Diniz LM. Cutaneous tuberculosis: a 26-year retrospective study in an endemic area of tuberculosis, Vitória, Espírito Santo, Brazil. Rev Inst Med Trop São Paulo. 2016;58:49. https://doi.org/10.1590/S1678-9946201658049.
Mervis JS, Machler BC, Hanly AJ, Federman DG. Down the rabbit hole: cutaneous tuberculosis. Am J Med. 2018;132(1):52–4. https://doi.org/10.1016/j.amjmed.2018.08.016.
Mann D, Sant’Anna FM, Schmaltz CAS, Freitas DFS, et al. Cutaneous tuberculosis and HIV infection at a referral centre in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2018;113(9):180–4. https://doi.org/10.1590/0074-02760180184.
Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol. 2007;25(2):173–80. https://doi.org/10.1016/j.clindermatol.2006.05.005.
Handog EB, Gabriel TG, Pineda RTV. Management of cutaneous tuberculosis. Dermatol Ther. 2008;21(3):154–61. https://doi.org/10.1111/j.1529-8019.2008.00186.x.
van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis. 2015;95(6):629–38. https://doi.org/10.1016/j.tube.2014.12.006.
Sethi A. Tuberculosis and infections with atypical mycobacteria. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick’s dermatology. 9th ed. Baltimore: McGraw-Hill Education; 2019. p. 2858–75. isbn:978-0-07-183783-5.
MacGregor RR. Cutaneous tuberculosis. Clin Dermatol. 1995;13(3):245–55. https://doi.org/10.1016/0738-081x(95)00019-c.
Wong HW, Tay YK, Sim CS. Papular eruption on a tattoo: a case of primary inoculation tuberculosis. Australas J Dermatol. 2005;46(2):84–7. https://doi.org/10.1111/j.1440-0960.2005.00147.x.
Kumar B, Rai R, Kaur I, Sahoo B, et al. Childhood cutaneous tuberculosis: a study over 25 years from northern India. Int J Dermatol. 2001;40(1):26–32. https://doi.org/10.1046/j.1365-4362.2001.01165.x.
Nakamura S, Hashimoto Y, Nishi K, Takahashi H, et al. Cutaneous tuberculosis simulating lymphocutaneous sporotrichosis. Australas J Dermatol. 2012;53(4):136–7. https://doi.org/10.1111/j.1440-0960.2012.00957.x.
Sehgal VN, Sehgal R, Bajaj P, Sriviastava G, et al. Tuberculosis verrucosa cutis (TBVC). J Eur Acad Dermatol Venereol. 2000;14(4):319–21. https://doi.org/10.1046/j.1468-3083.2000.00075-6.x.
Gruber PC, Whittam LR, du Vivier A. Tuberculosis verrucosa cutis on the sole of the foot. Clin Exp Dermatol. 2002;27(3):188–91. https://doi.org/10.1046/j.1365-2230.2002.00994.x.
Chahar M, Dhali TK, D’Souza P. Multifocal tuberculosis verrucosa cútis. Dermatol Online J. 2015;21(1):13030/qt80j7q792. PMID: 25612118.
Vashisht P, Sahoo B, Khurana N, Reddy BS. Cutaneous tuberculosis in children and adolescents: a clinicohistological study. J Eur Acad Dermatol Venereol. 2007;21(1):40–7. https://doi.org/10.1111/j.1468-3083.2006.01858.x.
Bellet JS, Prose NS. Skin complications of Bacillus Calmette-Guérin immunization. Curr Opin Infect Dis. 2005;18(2):97–100. https://doi.org/10.1097/01.qco.0000160895.97362.4f.
Yates VM, Walker SL. Chapter 27. Mycobacterial infections. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th ed. Oxford: Blackwell Publishing Ltd; 2016. p. 27.5–27.32. isbn:9781118441190.
Saritha M, Parveen BA, Anandan V, Priyavathani MR, et al. Atypical forms of lupus vulgaris—a case series. Int J Dermatol. 2009;48(2):150–3. https://doi.org/10.1111/j.1365-4632.2009.03863.x.
Ramesh V. Sporotrichoid cutaneous tuberculosis. Clin Exp Dermatol. 2007;32(6):680–2. https://doi.org/10.1111/j.1365-2230.2007.02481.x.
Motta A, Feliciani P, Toto P, De Benedetto A, et al. Lupus vulgaris developing at the site of misdiagnosed scrofuloderma. J Eur Acad Dermatol Venereol. 2003;17(3):313–5. https://doi.org/10.1046/j.1468-3083.2003.00783.x.
Gooptu C, Marks N, Thomas J, James MP. Squamous cell carcinoma associated with lupus vulgaris. Clin Exp Dermatol. 1998;23(3):99–102. https://doi.org/10.1046/j.1365-2230.1998.00346.x.
Zawirska A, Adamski Z, Stawicka E, Schwartz RA. Cutaneous squamous cell carcinoma developing in lupus vulgaris exfoliativus persistent for 40 years. Int J Dermatol. 2009;48(2):125–7. https://doi.org/10.1111/j.1365-4632.2009.03850.x.
Pacheco C, Silva E, Miranda J, Duarte R. Cutaneous tuberculosis as metastatic tuberculous abscess. J Bras Pneumol. 2015;41(2):200–2. https://doi.org/10.1590/S1806-37132015000004388.
Almagro M, Del Pozo J, Rodríguez-Lozano J, Silva JG, et al. Metastatic tuberculous abscesses in an immunocompetent patient. Clin Exp Dermatol. 2005;30(3):247–9. https://doi.org/10.1111/j.1365-2230.2005.01728.x.
Sezgin B, Atilganoglu U, Yigit O, Ergün SS, et al. Concomitant cutaneous metastatic tuberculous abscesses and multifocal skeletal tuberculosis. Indian J Dermatol. 2008;53(3):149–53. https://doi.org/10.4103/0019-5154.43208.
Gao W, Zeng Y, Chen W. Multiple subcutaneous tuberculous abscesses in a dermatomyositis patient without pulmonary tuberculosis: a case report and literature review. BMC Infect Dis. 2020;20:409. https://doi.org/10.1186/s12879-020-05137-w.
Daikos DL, Uttamchandani RB, Tuda C, Fischl MA, et al. Disseminated miliary tuberculosis of the skin in patients with AIDS. Clin Infect Dis. 1998;27(1):205–8. https://doi.org/10.1086/514608.
Sharma A, Pinto B, Dogra S, Sharma K, et al. A case series and review of Poncet’s disease, and the utility of current diagnostic criteria. Int J Rheum Dis. 2016;19:1010–7. https://doi.org/10.1111/1756-185X.12726.
Ramos-e-Silva M, Castro MCR. Mycobacterial infections. In: Bolognia JL, et al., editors. Dermatology. London: Elsevier; 2018. p. 1296–316. isbn:978-0-7020-6275-9.
Park YM, Kang H, Cho SH, Cho BK. Lichen scrofulosorum-like eruption localized to multipuncture BCG vaccination site. J Am Acad Dermatol. 1999;41(2):262–4. https://doi.org/10.1016/S0190-9622(99)70059-9.
Jacobsen G, Samolitis NJ, Harris RM. Lichenoid eruption in a patient with AIDS—Lichen scrofulosorum (LS) tuberculid with underlying MAC infection. Arch Dermatol. 2006;142(3):385–90. https://doi.org/10.1001/archderm.142.3.385-b.
Wong S, Rizvi H, Cerio R, O’Toole EA. An unusual case of vulval papulonecrotic tuberculid. Clin Exp Dermatol. 2011;36(3):277–80. https://doi.org/10.1111/j.1365-2230.2010.03925.x.
Freiman A, Ting P, Miller M, Greenway C. Papulonecrotic tuberculid: a rare form of cutaneous tuberculosis. Cutis. 2005;75(6):341–6. PMID: 16047872.
Kim GW, Park HJ, Kim HS, Chin HW, et al. Simultaneous occurrence of papulonecrotic tuberculid and erythema induratum in a patient with pulmonary tuberculosis. Pediatr Dermatol. 2013;30(2):256–9. https://doi.org/10.1111/j.1525-1470.2012.01744.x.
Kim GW, Park HJ, Kim HS, Kim SH, et al. Delayed diagnosis of scrofuloderma misdiagnosed as a bacterial abscess. Ann Dermatol. 2012;24(1):70–3. https://doi.org/10.5021/ad.2012.24.1.70.
von Huth S, Ovrehus AL, Lindahl KH, Johansen IS. Two cases of erythema induratum of Bazin—a rare cutaneous manifestation of tuberculosis. Int J Infect Dis. 2015;38:121–4. https://doi.org/10.1016/j.ijid.2015.08.002.
Mascaró JM Jr, Baselga E. Erythema induratum of Bazin. Dermatol Clin. 2008;26(4):439–45. https://doi.org/10.1016/j.det.2008.05.007.
Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnois and management. Dermatol Ther. 2010;23(4):320–7. https://doi.org/10.1111/j.1529-8019.2010.01332.x.
Sharon V, Goodarzi H, Chambers CJ, Fung MA, et al. Erythema induratum of Bazin. Dermatol Online J. 2010;16(4):1. PMID: 20409408.
Gupta V. Papulonecrotic tuberculid with scrofuloderma: an uncommon association. J Clin Diagn Res. 2015;9(2):WD03–4. https://doi.org/10.7860/JCDR/2015/10751.5524.
Magalhães TS, Dammert VG, Samorano LP, Litvoc MN, et al. Erythema induratum of Bazin: epidemiological, clinical and laboratorial profile of 54 patients. J Dermatol. 2018;45:628–9. https://doi.org/10.1111/1346-8138.14260.
Inoue T, Fukumoto T, Ansai S, Kimura T. Erythema induratum of Bazin in an infant after Bacille Calmette–Guerin vaccination. J Dermatol. 2006;33(4):268–72. https://doi.org/10.1111/j.1346-8138.2006.00065.x.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Guidelines for tuberculosis control in Brazil. Brasilia; 2011. 284p. https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z-1/t/tuberculose. Accessed 23 Dec 2020.
Almaguer-Chavez J, Ocampo-Candiani J, Rendon A. Current panorama in the diagnosis of cutaneous tuberculosis. Actas Dermosifiliogr. 2009;100(7):562–70. PMID: 19715641.
Tuberculin purified protein derivative (Tubersol®). PPD. https://www.drugs.com/pro/tubersol.html. Accessed 16 Dec 2020.
Tuberculin purified protein derivative (Aplisol®). PPD. https://www.drugs.com/cdi/aplisol.html. Accessed 16 Dec 2020.
Collins JM, Hunter M, Gordon W, Kempker RR, et al. False-positive tuberculin skin test results among low-risk healthcare workers following implementation of fifty-dose vials of purified protein derivative. Infect Control Hosp Epidemiol. 2018;39(6):750–2. https://doi.org/10.1017/ice.2018.59. PMID: 29606170; PMCID: PMC6393163.
Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192–204. PMID: 17131776.
Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356(9235):1099–104. https://doi.org/10.1016/S0140-6736(00)02742-2.
Ramam M, Malhotra A, Tejasvi T, Manchanda Y, Sharma S, Mittal R, et al. How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis? Int J Dermatol. 2011;50(11):1379–82. https://doi.org/10.1111/j.1365-4632.2011.04971.x.
Seddon JA, Paton J, Nademi Z, Keane D, et al. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax. 2016;71(10):932–9. https://doi.org/10.1136/thoraxjnl-2015-207687. PMID: 27335104; PMCID: PMC5036222.
Mancuso JD, Mody RM, Olsen CH, Harrison LH, et al. The long-term effect of Bacille Calmette-Guérin vaccination on tuberculin skin testing: a 55-year follow-up study. Chest. 2017;152:282–94. https://doi.org/10.1016/j.chest.2017.01.001.
Carter ER, Lee CM. Interpretation of the tuberculin skin test reaction by pediatric providers. Pediatr Infect Dis J. 2002;21(3):200–3. https://doi.org/10.1097/00006454-200203000-00008. PMID: 12005082.
Grabau JC, Hughes SE, Foster EA, et al. False-positive tuberculin skin tests in a state prison system. Int J Tuberc Lung Dis. 2003;7(1):93–7. PMID: 12701841.
de Medeiros VLS, Santos FCF, Montenegro LML, Silva MDC, et al. TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients. PLoS One. 2020;15(12):e0242098. https://doi.org/10.1371/journal.pone.0242098. PMID: 33270676; PMCID: PMC7714364.
Arias-Guillén M, Sánchez Menéndez MM, Alperi M, Riestra S, et al. High rates of tuberculin skin test positivity due to methotrexate therapy: false positive results? Semin Arthritis Rheum. 2018;48(3):538–46. https://doi.org/10.1016/j.semarthrit.2018.03.018. PMID: 29735171.
Almeida Santos J, Duarte R, Nunes C. Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis. Clin Respir J. 2020;14(6):541–8. https://doi.org/10.1111/crj.13166. PMID: 32052551.
Lee YM, Park KH, Kim SM, Park SJ, et al. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection. 2013;41(6):1089–95. https://doi.org/10.1007/s15010-013-0478-z. PMID: 23943073.
Assane K, Oumou NS, Mohamed C, Ndiaye ST, et al. Cutaneous tuberculosis in Dakar: 151 cases report. Mali Med. 2010;25(1):14–7. PMID: 21436010.
Marcoval J, Servitje O, Moreno A, Jucglà A, Peyrí J. Lupus vulgaris. Clinical, histopathologic, and bacteriologic study of 10 cases. J Am Acad Dermatol. 1992;26(3 Pt 2):404–7. PMID: 1564144.
Mazurek GH, Jereb J, Vernon A, LoBue P, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1–25. PMID: 20577159.
Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, et al. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med. 2013;187(2):206–11. https://doi.org/10.1164/rccm.201203-0430OC.
Simsek H, Alpar S, Ucar N, Aksu F, et al. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J Infect Dis. 2010;63(2):99–102. PMID: 20332570.
Di L, Li Y. The risk factor of false-negative and false-positive for T-SPOT.TB in active tuberculosis. J Clin Lab Anal. 2018;32(2):e22273. https://doi.org/10.1002/jcla.22273. PMID: 28594104; PMCID: PMC6817182.
Yamasue M, Komiya K, Usagawa Y, Umeki K, et al. Factors associated with false-negative interferon-γ release assay results in patients with tuberculosis: a systematic review with meta-analysis. Sci Rep. 2020;10(1):1607. https://doi.org/10.1038/s41598-020-58459-9. PMID: 32005930; PMCID: PMC6994686.
Wang MS, Liu XJ. Risk factors for false-negative interferon-γ release assay results in culture-confirmed childhood TB. Am J Trop Med Hyg. 2019;101(6):1303–7. https://doi.org/10.4269/ajtmh.18-0684. PMID: 31674295; PMCID: PMC6896862.
Santos JA, Duarte R, Nunes C. Host factors associated with false-negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis. Pulmonology. 2020;26(6):353–62. https://doi.org/10.1016/j.pulmoe.2019.11.001. PMID: 31843341.
Kay AW, Islam SM, Wendorf K, Westenhouse J, Barry PM. Interferon-γ release assay performance for tuberculosis in childhood. Pediatrics. 2018;141(6):e20173918. https://doi.org/10.1542/peds.2017-3918. PMID: 29728429.
Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177–84. https://doi.org/10.7326/0003-4819-149-3-200808050-00241.
Lai CC, Tan CK, Lin SH, Liu WL, et al. Diagnostic value of an enzyme-linked immunospot assay for interferon-γ in cutaneous tuberculosis. Diagn Microbiol Infect Dis. 2011;70(1):60–4. https://doi.org/10.1016/j.diagmicrobio.2010.11.012.
Cho K, Cho E, Kwon S, Im S, et al. Factors associated with indeterminate and false negative results of QuantiFERON-TB gold in-tube test in active tuberculosis. Tuberc Respir Dis (Seoul). 2012;72(5):416–25. https://doi.org/10.4046/trd.2012.72.5.416.
Chen Y, Jiang H, Zhang W, Chen Z, et al. Diagnostic value of T-SPOT.TB test in cutaneous mycobacterial infections. Acta Derm Venereol. 2018;98(10):989–90. https://doi.org/10.2340/00015555-3011. PMID: 30085325.
Chung HC, Kim BK, Hong H, Wang HY, et al. Interferon-γ release assay and reverse blot hybridization assay: diagnostic role in cutaneous tuberculosis. Acta Derm Venereol. 2016;96(1):126–7. https://doi.org/10.2340/00015555-2182. PMID: 26084370.
Vera-Kellet C, Peters L, Elwood K, Dutz JP. Usefulness of interferon- γ release assays in the diagnosis of erythema induratum. Arch Dermatol. 2011;147(8):949–52. https://doi.org/10.1001/archdermatol.2011.183.
Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol. 2009;161(4):797–800. https://doi.org/10.1111/j.1365-2133.2009.09331.x.
Perez-Velez CM. Pediatric tuberculosis: new guidelines and recommendations. Curr Opin Pediatr. 2012;24(3):319–28. https://doi.org/10.1097/MOP.0b013e32835357c3.
Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS. 2002;16(17):2285–93. https://doi.org/10.1097/00002030-200211220-00008.
Na SY, Park SY, Cho HH, Choi JW, et al. Application of IFN-γ releasing assay for the diagnosis of erythema induratum of Bazin. J Eur Acad Dermatol Venereol. 2014;28(1):41–5. https://doi.org/10.1111/jdv.12052. PMID: 23216422.
Koh HY, Tay LK, Pang SM, Ong BH. Changing the way we diagnose tuberculids with interferon-gamma release assays. Australas J Dermatol. 2012;53(1):73–5. https://doi.org/10.1111/j.1440-0960.2011.00791.x. PMID: 22309338.
El-Khalawany M, Meraag I, Eassa B, El-Naby HH. Clinicopathological features and the practice of diagnosing infectious cutaneous granulomas in Egypt. Int J Infect Dis. 2011;15(9):620–6. https://doi.org/10.1016/j.ijid.2011.04.014.
Mann D, Sant’Anna FM, Schmaltz CAS, Rolla V, et al. Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases. Int J Dermatol. 2019;58(12):1451–9. https://doi.org/10.1111/ijd.14617. PMID: 31553059.
Aggarwal P, Singal A, Bhattacharya SN, Mishra K. Comparison of the radiometric BACTEC 460 TB culture system and Lowenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern. Int J Dermatol. 2008;47(7):681–7. https://doi.org/10.1111/j.1365-4632.2008.03675.x.
Umapathy KC, Begum R, Ravichandran G, Rahman F, et al. Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Tropical Med Int Health. 2006;11:1521–8. https://doi.org/10.1111/j.1365-3156.2006.01705.x.
Zouhair K, Akhdari N, Nejjam F, Ouazzani T, et al. Cutaneous tuberculosis in Morocco. Int J Infect Dis. 2007;11(3):209–12. https://doi.org/10.1016/j.ijid.2006.02.009.
Chong LY, Lo KK. Cutaneous tuberculosis in Hong Kong. A 10-year retrospective study. Int J Dermatol. 1995;34:26–9. https://doi.org/10.1111/j.1365-4362.1995.tb04372.x.
Abdalla CM, de Oliveira ZN, Sotto MN, Leite KR, et al. Polymerase chain reaction compared to other laboratory findings and to clinical evaluation in the diagnosis of cutaneous tuberculosis and atypical mycobacteria skin infection. Int J Dermatol. 2009;48(1):27–35. https://doi.org/10.1111/j.1365-4632.2009.03807.x.
Mei Y, Zhang W, Shi Y, Jiang H, et al. Cutaneous tuberculosis and nontuberculous mycobacterial infections at a National Specialized Hospital in China. Acta Derm Venereol. 2019;99(11):997–1003. https://doi.org/10.2340/00015555-3283. PMID: 31396633.
Coros A, DeConno E, Derbyshire KM. IS6110, a Mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species. J Bacteriol. 2008;190(9):3408–10. https://doi.org/10.1128/JB.00009-08.
Cortez MV, Oliveira CM, Monte RL, Araujo JR, et al. HIV-associated tuberculous lymphadenitis: the importance of polymerase chain reaction (PCR) as a complementary tool for the diagnosis of tuberculosis—a study of 104 patients. An Bras Dermatol. 2011;86(5):925–31. https://doi.org/10.1590/S0365-05962011000500010.
Barrios-Payan J, Saqui-Salces M, Jeyanathan M, Alcantara-Vazquez A, et al. Extrapulmonary locations of Mycobacterium tuberculosis DNA during latent infection. J Infect Dis. 2012;206(8):1194–205. https://doi.org/10.1093/infdis/jis381.
Tortoli E, Urbano P, Marcelli F, Simonetti TM, et al. Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples? J Clin Microbiol. 2012;50(8):2810–3. https://doi.org/10.1128/JCM.01412-12.
Goncalves MG, Fukasawa LO, Oliveira RS, Salgado MM, et al. Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR. Mem Inst Oswaldo Cruz. 2012;107(7):903–8. https://doi.org/10.1590/S0074-02762012000700011.
Afsar I, Afsar FS. Evaluation of laboratory diagnosis for cutaneous tuberculosis. Indian J Pathol Microbiol. 2016;59(3):274–8. https://doi.org/10.4103/0377-4929.188132. PMID: 27510659.
Agarwal P, Singh EN, Agarwal US, Meena R, et al. The role of DNA polymerase chain reaction, culture and histopathology in the diagnosis of cutaneous tuberculosis. Int J Dermatol. 2017;56(11):1119–24. https://doi.org/10.1111/ijd.13708. PMID: 28791686.
Malhotra S, Nair D, Ramesh V, Sehgal VN. Comparative evaluation of molecular tests Vis-à-Vis culture and treatment response in the diagnosis of cutaneous tuberculosis. Skinmed. 2018;16(5):301–3. PMID: 30413222.
Suthar C, Rana T, Singh UB, Singh M, et al. mRNA and DNA PCR tests in cutaneous tuberculosis. Indian J Dermatol Venereol Leprol. 2013;79(1):65–9. https://doi.org/10.4103/0378-6323.104671. PMID: 23254731.
Maldonado-Bernal C, Ramos-Garibay A, Rios-Sarabia N, Serrano H, et al. Nested polymerase chain reaction and cutaneous tuberculosis. Am J Dermatopathol. 2019;41(6):428–35. https://doi.org/10.1097/DAD.0000000000001315. PMID: 30531542.
Tan SH, Tan HH, Sun YJ, Goh CL. Clinical utility of polymerase chain reaction in the detection of Mycobacterium tuberculosis in different types of cutaneous tuberculosis and tuberculids. Ann Acad Med Singap. 2001;30(1):3–10. PMID: 11242621.
Hsiao PF, Tzen CY, Chen HC, Su HY. Polymerase chain reaction based detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Int J Dermatol. 2003;42(4):281–6. https://doi.org/10.1046/j.1365-4362.2003.01461.x.
Senturk N, Sahin S, Kocagoz T. Polymerase chain reaction in cutaneous tuberculosis: is it a reliable diagnostic method in paraffin-embedded tissues? Int J Dermatol. 2002;41(12):863–6. https://doi.org/10.1046/j.1365-4362.2002.01604.
Freitas FAD, Siqueira HR, Albano RM. Molecular methods in diagnosis of tuberculosis and resistance of Mycobacterium tuberculosis to drugs. Pulmao RJ. 2009;18(2):96–101.
Lucas S. Bacterial diseases. In: Elder DE, Elenitsas R, Murphy GF, et al., editors. Lever’s histopathology of the skin. 10th ed. Philadelphia: Lippincott; 2009. p. 513–50. isbn:9781451190373.
Zuñiga J, Torres-García D, Santos-Mendoza T, Rodriguez-Reyna TS, et al. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol. 2012;2012:193923. https://doi.org/10.1155/2012/193923.
Pai VV, Naveen KN, Athanikar SB, Dinesh US, et al. A clinico-histopathological study of lupus vulgaris: a 3 year experience at a tertiary care centre. Indian Dermatol Online J. 2014;5(4):461–5. https://doi.org/10.4103/2229-5178.142497.
Sharma S, Sehgal VN, Bhattacharya SN, Mahajan G, Gupta R. Clinicopathologic spectrum of cutaneous tuberculosis: a retrospective analysis of 165 Indians. Am J Dermatopathol. 2015;37(6):444–50. https://doi.org/10.1097/DAD.0000000000000297.
Yates VM, Walker SL. Chapter 27. Mycobacterial infections. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th ed. Oxford: Blackwell Publishing Ltd; 2016. p. 27.5–27.47. isbn:9781118441190.
Singal A, Bhattacharya SN. Lichen scrofulosorum: a prospective study of 39 patients. Int J Dermatol. 2005;44(6):489–93. https://doi.org/10.1111/j.1365-4632.2005.02499.x.
Bilan P, Sin C, Wann AR, Grossin M, et al. Cutaneous tuberculosis and erythema induratum: a retrospective study of 13 cases in France. Ann Dermatol Venereol. 2015;142(4):237–44. https://doi.org/10.1016/j.annder.2015.01.015.
Jordaan HF, van Niekerk DJ, Louw M. Papulonecrotic tuberculid. A clinical, histopathological, and immunohistochemical study of 15 patients. Am J Dermatopathol. 1994;16(5):474–85. PMID: 7802163.
Choi SR, Kim JK, Kim DH, Yoon MS. A case of tuberculosis cutis orificialis with perianal involvement. Ann Dermatol. 2009;21(4):443–6. https://doi.org/10.5021/ad.2009.21.4.443.
Hadj I, Meziane M, Mikou O, Inani K, et al. Tuberculous gummas with sporotrichoid pattern in a 57-year-old female: a case report and review of the literature. Int J Mycobacteriol. 2014;3(1):66–70. https://doi.org/10.1016/j.ijmyco.2013.10.007.
Regnier S, Ouagari Z, Perez ZL, Veziris N, et al. Cutaneous miliary resistant tuberculosis in a patient infected with human immunodeficiency virus: case report and literature review. Clin Exp Dermatol. 2009;34(8):e690–2. https://doi.org/10.1111/j.1365-2230.2009.03425.x.
Thakur BK, Verma S, Hazarika D. A clinicopathological study of cutaneous tuberculosis at Dibrugarh District, Assam. Indian J Dermatol. 2012;57(1):63–5. https://doi.org/10.4103/0019-5154.92685.
Dwari BC, Ghosh A, Paudel R, Kishore P. A clinicoepidermiological study of 50 cases of cutaneous tuberculosis in a tertiary care teaching hospital in Pokhara, Nepal. Indian J Dermatol. 2010;55(3):233–7. https://doi.org/10.4103/0019-5154.70670.
Mathur M, Pandey SN. Clinico histological profile of cutaneous tuberculosis in Central Nepal. Kathmandu Univ Med J. 2014;12(4):238–41. https://doi.org/10.3126/kumj.v12i4.13727.
Punia RS, Aggarwal P, Kundu R, Mohan H, et al. Cutaneous tuberculosis: a clinicopathological study of 50 cases from a tertiary care referral hospital. Appl Med Res. 2015;1(3):104–8. https://doi.org/10.5455/amr.20150412074909.
Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses. Hum Pathol. 1982;13(5):485–95. https://doi.org/10.1016/s0046-8177(82)80032-4.
Min KW, Ko JY, Park CK. Histopathological spectrum of cutaneous tuberculosis and non-tuberculous mycobacterial infections. J Cutan Pathol. 2012;39(6):582–95. https://doi.org/10.1111/j.1600-0560.2012.01903.x.
Paksoy N, Hekim E. Comparative analysis of the clinicopathological features in cutaneous leishmaniasis and lupus vulgaris in Turkey. Trop Med Parasitol. 1993;44(1):37–9. PMID: 8516631.
Nirmala V, Chacko CJ, Job CK. Tuberculoid leprosy and tuberculosis skin: a comparative histopathological study. Lepr India. 1977;49(1):65–9. PMID: 895075.
Leitao CCSL, Campelo ARL, Dantas AT. Tuberculose. In: Filgueira NA, Costa Jr JI, Lucena VG, Leitao CCS, Kitner D, Mendes JM, et al., editors. Condutas em clinica medica. 4th ed. Rio de Janeiro: Guanabara Koogan; 2007. p. 568–82.
Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva PG, Medeiros VLS. Cutaneous tuberculosis: diagnosis, histopathology and treatment—part II. An Bras Dermatol. 2014;89(4):545–55. https://doi.org/10.1590/abd1806-4841.20142747.
Nagarajan S, Whitaker P. Management of adverse reactions to first-line tuberculosis antibiotics. Curr Opin Allergy Clin Immunol. 2018;18(4):333–41. https://doi.org/10.1097/ACI.0000000000000462. PMID: 29901473.
Ramesh V, Sen MK, Sethuraman G, D’Souza P. Cutaneous tuberculosis due to multidrug-resistant tubercle bacilli and difficulties in clinical diagnosis. Indian J Dermatol Venereol Leprol. 2015;81(4):380–4. https://doi.org/10.4103/0378-6323.157447.
Arbex MA, Varella MCL, Siqueira HR, Mello FAF. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations—part 1: first-line drugs. J Bras Pneumol. 2010;36(5):626–40. https://doi.org/10.1590/S1806-37132010000500016.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Glossary
- Acid-fast bacilli (AFB)
-
Testing may be used to detect several different types of acid-fast bacilli, but it is most commonly used to identify an active tuberculosis infection caused by the most medically important AFB, Mycobacterium tuberculosis. Are called acid-fast bacilli because they are rod-shaped bacteria (bacilli) that can be seen under the microscope following a staining procedure whereby the bacteria retain the color of the stain after an acid wash (acid-fast).
- Bacille Calmette-Guérin (BCG)
-
Vaccine (strain 1331) is a live mycobacteria vaccine derived from attenuated strains of Mycobacterium bovis to prevent tuberculosis and other mycobacterial infections. BCG has been recommended only for immunocompetent children and adults who have high risk of ongoing exposure that cannot be avoided. In addition, it is used as an immunostimulant in the treatment of several diseases.
- Erythema induratum of Bazin (EIB)
-
Is a granulomatous lobular panniculitis associated with tuberculosis, which affects the lower limbs of young and middle-aged women.
- Erythema nodosum
-
Is characterized by the presence of nodular swelling, hardened, nonulcerative nodules which are seen predominantly in the lower limbs of women.
- Interferon-γ release assay (IGRA)
-
Are tests used to identify indirectly a cellular immune response specific to peptides present in the MTB. Currently, there are two commercially available tests approved by the FDA, which use different techniques, the T-SPOT®.TB test and the QuantiFERON® TB Gold Plus (QFT-plus) test.
- Lupus vulgaris
-
Is a chronic, progressive, and potentially disfiguring form of cutaneous tuberculosis, which occurs in patients with a high degree of immunity against Mycobacterium tuberculosis.
- Scrofuloderma
-
Also known as tuberculosis colliquativa cutis, is the most common form of CTB in developing countries such as Brazil and India and can occur at any age, although children, adolescents, and the elderly are the most affected.
- Tuberculids
-
Are considered hypersensitivity reactions to M. tuberculosis antigens present in extracutaneous focus or, rarely, after BCG vaccination.
- Tuberculin skin test
-
(Mantoux technique, PPD, TST) technique consists in one injection of Purified Protein Derivative (PPD) of Mycobacterium tuberculosis in the superficial dermis, in the middle third of the left forearm. The TST is a delayed hypersensitivity type IV reaction induced by T lymphocytes.
- Tuberculous gumma
-
Also called metastatic tuberculous abscess, is a multibacillary cutaneous tuberculosis. It results from the hematogenous dissemination of the bacillus by an active tuberculosis primary focus, especially in periods of decreased cellular immunity.
- Tuberculosis verrucosa cutis
-
Is the most common form of exogenous cutaneous tuberculosis. The lesion develops from direct inoculation in the skin of previously sensitized individuals with moderate to high immunity against Mycobacterium tuberculosis.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
dos Santos, J.B., de Oliveira, I.C.F., de Fátima Medeiros Brito, M., Carrera, M.C., Parisio, V.P., de Medeiros, V.L.S. (2023). Tuberculosis. In: Rangel Bonamigo, R. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-031-13505-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-031-13505-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13504-0
Online ISBN: 978-3-031-13505-7
eBook Packages: MedicineMedicine (R0)